Literature DB >> 7959581

The etiology of chronic hepatitis in Italy: a multicenter study.

G Giusti1, E Sagnelli, C Gallo, F Piccinino, B Galanti, G B Gaeta.   

Abstract

In a multicenter retrospective study, we reviewed the etiology of chronic hepatitis (CH) in Italy during the period 1980-1989, before the laboratory diagnosis of HCV hepatitis had become possible. Among the 5,461 patients investigated, 31.3% had HBV-CH, 5.5% HDV-CH, 3.0% serological markers of autoimmune hepatitis and 3.7% post-transfusion NANB CH. Alcohol abuse was considered responsible in 10.9% of the cases and a diagnosis of crytogenic CH was made in 42.5%. Considering that most cryptogenic cases were actually due to chronic HCV infection, we may assume that as many as two-thirds of our cases were due to a hepatitis virus infection. Some differences were observed between patients with chronic hepatitis of different etiologies. Drug abuse was frequently recorded only in HDV-CH; patients with HBV-CH and HCV-CH were younger than those in other etiological groups; a histological picture of chronic active hepatitis was more frequently recorded in HDV-CH and autoimmune CH. The only identifiable geographical differences observed were a higher prevalence of HDV-CH in the south and of alcoholic chronic liver diseases in the north. During the period under observation, we noted a clear reduction in the percentages of HBV chronic hepatitis cases after 1984 and, accordingly, the mean age of HBV-CH progressively increased from 1980 to 1989 by almost a year each year. This observation is in agreement with recent data suggesting a reduction in HBV endemicity in Italy in recent years.

Entities:  

Mesh:

Year:  1994        PMID: 7959581

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy.

Authors:  M De Paschale; M T Manco; L Belvisi; C Magnani; T Re; P Viganò; S Biagiotti; F Capelli; A Mazzone; M P Baldacci; A Ferrara; A L Neri; C M Guastoni; R A Bonazzina; B Brando; P Clerici
Journal:  Infection       Date:  2012-02-25       Impact factor: 3.553

2.  Impact of comorbidities on the severity of chronic hepatitis B at presentation.

Authors:  Evangelista Sagnelli; Tommaso Stroffolini; Alfonso Mele; Michele Imparato; Caterina Sagnelli; Nicola Coppola; Piero Luigi Almasio
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

Review 3.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Margherita Macera; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country.

Authors:  Tommaso Stroffolini; Filomena Morisco; Luigina Ferrigno; Giuseppina Pontillo; Giuseppina Iantosca; Valentina Cossiga; Simonetta Crateri; Maria Elena Tosti
Journal:  Viruses       Date:  2022-01-26       Impact factor: 5.048

Review 5.  Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years.

Authors:  Caterina Sagnelli; Antonello Sica; Massimiliano Creta; Armando Calogero; Massimo Ciccozzi; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

6.  Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy.

Authors:  Rosa Zampino; Nicolina Capoluongo; Adriana Boemio; Margherita Macera; Martina Vitrone; Luigi Elio Adinolfi; Pietro Filippini; Evangelista Sagnelli; Caterina Sagnelli; Emanuele Durante-Mangoni; Nicola Coppola
Journal:  Can J Gastroenterol Hepatol       Date:  2018-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.